Literature DB >> 20299807

Development and validation of a self-administered questionnaire for myasthenia gravis patients.

A H Maniaol1, C Brunborg, C M E Tallaksen.   

Abstract

BACKGROUND: To date, the investigation of the epidemiological profile of myasthenia gravis (MG) is sparse, and the influence of environmental and lifestyle factors on the occurrence of the disease remains thus unknown. The main aim of this study, which is part of a European collaborative project (EuroMyasthenia), was to develop a self-administered questionnaire to investigate these potential predisposing factors for MG. No instrument for investigating these particular factors has previously been designed for MG patients.
MATERIAL AND METHODS: The questionnaire was developed in 3 stages: (1) devising a draft questionnaire based on questions derived from previously validated questionnaires and self-designed questions on MG characteristics; (2) testing the questionnaire on Norwegian MG patients (n = 57), and (3) assessing the content and criterion validity, and test-retest reliability, of the final questionnaire.
RESULTS: The questionnaire was easy to use and showed good feasibility for MG patients. Psychometric evaluation established the validity and reliability of the self-designed questions on MG characteristics.
CONCLUSION: This is the first validated instrument developed to identify self-assessed environmental factors and potential predisposing factors for MG, and suitable for use in large-scale epidemiological studies. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20299807     DOI: 10.1159/000297753

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

1.  Psychosocial aspects in myasthenic patients treated by plasmapheresis.

Authors:  Yu-Tai Chen; Yuanmay Chang; Hou-Chang Chiu; Jiann-Horng Yeh
Journal:  J Neurol       Date:  2011-02-02       Impact factor: 4.849

2.  Increased risk for clinical onset of myasthenia gravis during the postpartum period.

Authors:  Marion I Boldingh; Angelina H Maniaol; Cathrine Brunborg; Harald Weedon-Fekjær; Jan J G M Verschuuren; Chantal M E Tallaksen
Journal:  Neurology       Date:  2016-10-21       Impact factor: 9.910

3.  Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.

Authors:  Marte Wendel Gustavsen; Christian Magnus Page; Stine Marit Moen; Anja Bjølgerud; Pål Berg-Hansen; Gro Owren Nygaard; Leiv Sandvik; Benedicte Alexandra Lie; Elisabeth Gulowsen Celius; Hanne F Harbo
Journal:  BMC Neurol       Date:  2014-10-03       Impact factor: 2.474

4.  Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries.

Authors:  Liis Sabre; Elisabet Westerberg; Maarika Liik; Anna R Punga
Journal:  Brain Behav       Date:  2017-03-01       Impact factor: 2.708

5.  An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts.

Authors:  M I Boldingh; L Dekker; A H Maniaol; C Brunborg; A F Lipka; E H Niks; J J G M Verschuuren; C M E Tallaksen
Journal:  Health Qual Life Outcomes       Date:  2015-08-01       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.